ID   ACV1C_HUMAN             Reviewed;         493 AA.
AC   Q8NER5; Q4ZFZ8; Q86UL1; Q86UL2; Q8TBG2;
DT   25-OCT-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   05-OCT-2010, entry version 78.
DE   RecName: Full=Activin receptor type-1C;
DE            EC=2.7.11.30;
DE   AltName: Full=Activin receptor type IC;
DE            Short=ACTR-IC;
DE   AltName: Full=Activin receptor-like kinase 7;
DE            Short=ALK-7;
DE   Flags: Precursor;
GN   Name=ACVR1C; Synonyms=ALK7;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND
RP   MUTAGENESIS OF LYS-222.
RC   TISSUE=Brain;
RX   PubMed=12063393;
RA   Bondestam J., Huotari M.-A., Moren A., Ustinov J., Kaivo-Oja N.,
RA   Kallio J., Horelli-Kuitunen N., Aaltonen J., Fujii M., Moustakas A.,
RA   Ten Dijke P., Otonkoski T., Ritvos O.;
RT   "cDNA cloning, expression studies and chromosome mapping of human type
RT   I serine/threonine kinase receptor ALK7 (ACVR1C).";
RL   Cytogenet. Cell Genet. 95:157-162(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), SUBCELLULAR
RP   LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Placenta;
RX   MEDLINE=22592325; PubMed=12606401; DOI=10.1095/biolreprod.102.013045;
RA   Roberts H.J., Hu S., Qiu Q., Leung P.C.K., Caniggia I., Gruslin A.,
RA   Tsang B., Peng C.;
RT   "Identification of novel isoforms of activin receptor-like kinase 7
RT   (ALK7) generated by alternative splicing and expression of ALK7 and
RT   its ligand, Nodal, in human placenta.";
RL   Biol. Reprod. 68:1719-1726(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, AND MUTAGENESIS OF THR-194 AND LYS-222.
RX   PubMed=15531507; DOI=10.1210/jc.2004-0893;
RA   Xu G., Zhong Y., Munir S., Yang B.B., Tsang B.K., Peng C.;
RT   "Nodal induces apoptosis and inhibits proliferation in human
RT   epithelial ovarian cancer cells via activin receptor-like kinase 7.";
RL   J. Clin. Endocrinol. Metab. 89:5523-5534(2004).
RN   [6]
RP   VARIANTS [LARGE SCALE ANALYSIS] THR-195; ARG-216; ARG-267; VAL-355 AND
RP   VAL-482.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Serine/threonine protein kinase which forms a receptor
CC       complex on ligand binding. The receptor complex consisting of 2
CC       type II and 2 type I transmembrane serine/threonine kinases. Type
CC       II receptors phosphorylate and activate type I receptors which
CC       autophosphorylate, then bind and activate SMAD transcriptional
CC       regulators, SMAD2 and SMAD3. Receptor for activin AB, activin B
CC       and NODAL. Plays a role in cell differentiation, growth arrest and
CC       apoptosis.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR: Magnesium or manganese.
CC   -!- SUBUNIT: Binds the type 2 receptor protein ACVR2A (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NER5-1; Sequence=Displayed;
CC       Name=2; Synonyms=B, soluble B;
CC         IsoId=Q8NER5-2; Sequence=VSP_051841;
CC       Name=3; Synonyms=A, soluble A;
CC         IsoId=Q8NER5-3; Sequence=VSP_051842;
CC       Name=4; Synonyms=Truncated;
CC         IsoId=Q8NER5-4; Sequence=VSP_051840;
CC   -!- TISSUE SPECIFICITY: Present in pancreas, heart, colon, small
CC       intestine, ovary and the hippocampus, medulla oblongata and
CC       putamen of the brain. Isoform 1, isoform 2, isoform 3 and isoform
CC       4 are all expressed in the placenta throughout pregnancy.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily.
CC   -!- SIMILARITY: Contains 1 GS domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AY127050; AAM93495.1; -; mRNA.
DR   EMBL; AF525679; AAP21993.1; -; mRNA.
DR   EMBL; AF525680; AAP21994.1; -; mRNA.
DR   EMBL; AF525681; AAP21995.1; -; mRNA.
DR   EMBL; AC019186; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079750; AAX88951.1; -; Genomic_DNA.
DR   EMBL; BC022530; AAH22530.1; -; mRNA.
DR   IPI; IPI00302552; -.
DR   IPI; IPI00384221; -.
DR   IPI; IPI00384222; -.
DR   IPI; IPI00654757; -.
DR   RefSeq; NP_001104501.1; -.
DR   RefSeq; NP_001104502.1; -.
DR   RefSeq; NP_001104503.1; -.
DR   RefSeq; NP_660302.2; -.
DR   UniGene; Hs.562901; -.
DR   ProteinModelPortal; Q8NER5; -.
DR   SMR; Q8NER5; 25-97, 161-489.
DR   STRING; Q8NER5; -.
DR   PRIDE; Q8NER5; -.
DR   Ensembl; ENST00000243349; ENSP00000243349; ENSG00000123612.
DR   GeneID; 130399; -.
DR   KEGG; hsa:130399; -.
DR   UCSC; uc002tzk.2; human.
DR   UCSC; uc002tzl.2; human.
DR   UCSC; uc010foe.1; human.
DR   UCSC; uc010fof.1; human.
DR   CTD; 130399; -.
DR   GeneCards; GC02M158352; -.
DR   H-InvDB; HIX0002523; -.
DR   HGNC; HGNC:18123; ACVR1C.
DR   HPA; HPA007982; -.
DR   HPA; HPA011933; -.
DR   MIM; 608981; gene.
DR   PharmGKB; PA134908988; -.
DR   eggNOG; prNOG08019; -.
DR   HOGENOM; HBG314718; -.
DR   HOVERGEN; HBG054502; -.
DR   InParanoid; Q8NER5; -.
DR   OMA; RKKKRPN; -.
DR   OrthoDB; EOG9B5RQK; -.
DR   PhylomeDB; Q8NER5; -.
DR   BRENDA; 2.7.11.30; 247.
DR   NextBio; 82739; -.
DR   ArrayExpress; Q8NER5; -.
DR   Bgee; Q8NER5; -.
DR   CleanEx; HS_ACVR1C; -.
DR   Genevestigator; Q8NER5; -.
DR   GermOnline; ENSG00000123612; Homo sapiens.
DR   GO; GO:0048179; C:activin receptor complex; IDA:UniProtKB.
DR   GO; GO:0016361; F:activin receptor activity, type I; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IC:UniProtKB.
DR   GO; GO:0006915; P:apoptosis; IEA:UniProtKB-KW.
DR   GO; GO:0030154; P:cell differentiation; IDA:UniProtKB.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IC:UniProtKB.
DR   GO; GO:0042981; P:regulation of apoptosis; IDA:UniProtKB.
DR   InterPro; IPR000472; Activin_rcpt.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR003605; TGF_beta_rcpt_GS.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   SMART; SM00467; GS; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Apoptosis; ATP-binding; Complete proteome;
KW   Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Polymorphism; Receptor;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     20       Potential.
FT   CHAIN        21    493       Activin receptor type-1C.
FT                                /FTId=PRO_0000042628.
FT   TOPO_DOM     22    113       Extracellular (Potential).
FT   TRANSMEM    114    134       Helical; (Potential).
FT   TOPO_DOM    135    493       Cytoplasmic (Potential).
FT   DOMAIN      165    194       GS.
FT   DOMAIN      195    485       Protein kinase.
FT   NP_BIND     201    209       ATP (By similarity).
FT   ACT_SITE    323    323       Proton acceptor (By similarity).
FT   BINDING     222    222       ATP (By similarity).
FT   VAR_SEQ       1     50       Missing (in isoform 4).
FT                                /FTId=VSP_051840.
FT   VAR_SEQ     102    258       Missing (in isoform 2).
FT                                /FTId=VSP_051841.
FT   VAR_SEQ     102    181       Missing (in isoform 3).
FT                                /FTId=VSP_051842.
FT   VARIANT     195    195       I -> T.
FT                                /FTId=VAR_041407.
FT   VARIANT     216    216       G -> R.
FT                                /FTId=VAR_041408.
FT   VARIANT     267    267       W -> R (in a lung squamous cell carcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041409.
FT   VARIANT     355    355       I -> V.
FT                                /FTId=VAR_041410.
FT   VARIANT     482    482       I -> V (in dbSNP:rs7594480).
FT                                /FTId=VAR_041411.
FT   MUTAGEN     194    194       T->D: Pro-apoptotic.
FT   MUTAGEN     222    222       K->R: Loss of response to NODAL and SMAD2
FT                                phosphorylation.
FT   CONFLICT    231    231       S -> Y (in Ref. 4; AAH22530).
FT   CONFLICT    289    289       V -> M (in Ref. 4; AAH22530).
SQ   SEQUENCE   493 AA;  54871 MW;  5A10F259679204CB CRC64;
     MTRALCSALR QALLLLAAAA ELSPGLKCVC LLCDSSNFTC QTEGACWASV MLTNGKEQVI
     KSCVSLPELN AQVFCHSSNN VTKTECCFTD FCNNITLHLP TASPNAPKLG PMELAIIITV
     PVCLLSIAAM LTVWACQGRQ CSYRKKKRPN VEEPLSECNL VNAGKTLKDL IYDVTASGSG
     SGLPLLVQRT IARTIVLQEI VGKGRFGEVW HGRWCGEDVA VKIFSSRDER SWFREAEIYQ
     TVMLRHENIL GFIAADNKDN GTWTQLWLVS EYHEQGSLYD YLNRNIVTVA GMIKLALSIA
     SGLAHLHMEI VGTQGKPAIA HRDIKSKNIL VKKCETCAIA DLGLAVKHDS ILNTIDIPQN
     PKVGTKRYMA PEMLDDTMNV NIFESFKRAD IYSVGLVYWE IARRCSVGGI VEEYQLPYYD
     MVPSDPSIEE MRKVVCDQKF RPSIPNQWQS CEALRVMGRI MRECWYANGA ARLTALRIKK
     TISQLCVKED CKA
//
